Igor Branchi

Loop profile Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Genome Wide Analysis

Major Depressive Disorder

Prefrontal Cortex

Top Venues

The European journal of neuroscience

The pharmacogenomics journal

Translational psychiatry

Neural plasticity

Sapienza University of Rome

Université d'Orléans (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Sapienza University of Rome

Italy

Visiting Professor of Behavioral Science and Ethology

University of Zurich

Switzerland

Marie Curie fellowship Experienced Researcher/Visiting scientist :: Institute of Anatomy

Conseil National de la Recherche Scientifique

France

PhD student :: Institute de Transgenose

Education History

Université d'Orléans

France

PHD

Publications

Igor Branchi
Uncovering the determinants of brain functioning, behavior and their interplay in the light of context. The European journal of neuroscience (2024)
Igor Branchi
Uncovering the determinants of brain functioning, behavior and their interplay in the light of context. The European journal of neuroscience 60 (5) (2024)
Claudia Delli Colli, Marta Borgi, Silvia Poggini, Flavia Chiarotti, Francesca Cirulli, Brenda W J H Penninx, Francesco Benedetti, Benedetta Vai, Igor Branchi
Time moderates the interplay between 5-HTTLPR and stress on depression risk: gene x environment interaction as a dynamic process. Translational psychiatry 12 (1) (2022)
Silvia Poggini, Maria Teresa Golia, Silvia Alboni, Giampaolo Milior, Livio Pepè Sciarria, Aurelia Viglione, Gloria Matte Bon, Nicoletta Brunello, Stefano Puglisi-Allegra, Cristina Limatola, Laura Maggi, Igor Branchi
Combined Fluoxetine and Metformin Treatment Potentiates Antidepressant Efficacy Increasing IGF2 Expression in the Dorsal Hippocampus. Neural plasticity 2019 (2019)
Aurelia Viglione, Flavia Chiarotti, Silvia Poggini, Alessandro Giuliani, Igor Branchi
Predicting antidepressant treatment outcome based on socioeconomic status and citalopram dose. The pharmacogenomics journal 19 (6) (2019)